Human natural killer cell function and their interactions with dendritic cells

被引:29
作者
Moretta, L
Ferlazzo, G
Mingari, MC
Melioli, G
Moretta, A
机构
[1] Ist Giannina Gaslini, I-16148 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[3] Univ Genoa, Ctr Eccellenza Ric Biomed, I-13162 Genoa, Italy
[4] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[5] Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy
关键词
NK cells; dendritic cells; HLA class I-specific NK receptors;
D O I
10.1016/S0264-410X(03)00197-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells have long been considered as "primitive" and "non-specific" effector cells. However, the past 10 years have witnessed dramatic progress in our understanding of how NK cells function and their role in innate defenses. Thanks to specialized inhibitory receptors specific for MHC-class I molecules, they can sense the decrease or loss of these molecules, a typical condition of potentially dangerous cells such as tumor or virally-infected cells. NK cell triggering and lysis of these cells is mediated by several activating receptors and co-receptors that have recently been identified and cloned. While normal cells are usually resistant to the NK-mediated attack, a remarkable exception is represented by dendritic cells (DC). In their immature form (iDC), they are susceptible to NK-mediated lysis because of the expression of low levels of surface MHC-class I molecules. Since the process of DC maturation (mDC) is characterized by the surface expression of high levels of MHC-class I molecules, mDC become resistant to NK cells. Exposure to live bacteria induces rapid DC maturation and, thus, resistance to NK cells. The cross-talk between DC and NK cells is more complex and involves also a DC-dependent NK cell activation and proliferation. Thus, two important players of the innate immunity may be involved in a coordinated regulation of critical events occurring at the interface between innate and adaptive immunity. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S38 / S42
页数:5
相关论文
共 59 条
[1]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[4]  
Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO
[5]  
2-O
[6]   The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions [J].
Biassoni, R ;
Cantoni, C ;
Falco, M ;
Verdiani, S ;
Bottino, C ;
Vitale, M ;
Conte, R ;
Poggi, A ;
Moretta, A ;
Moretta, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :645-650
[7]   A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation [J].
Bottino, C ;
Sivori, S ;
Vitale, M ;
Cantoni, C ;
Falco, R ;
Pende, D ;
Morelli, L ;
Augugliaro, R ;
Semenzato, G ;
Biassoni, R ;
Moretta, L ;
Moretta, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) :1816-1824
[8]   GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease [J].
Bottino, C ;
Falco, M ;
Parolini, S ;
Marcenaro, E ;
Augugliaro, R ;
Sivori, S ;
Landi, E ;
Biassoni, R ;
Notarangelo, LD ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) :235-246
[9]  
Brandau S, 2001, INT J CANCER, V92, P697, DOI 10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO
[10]  
2-Z